Aytu BioScience (AYTU) Misses Q2 EPS by 4c

Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($0.04). Revenue for the quarter came in at $22.93 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• Albertsons (ACI) Misses Q1 EPS by 12c; offers guidance
• First Mid Bancshares, Inc. (FMBH) Tops Q2 EPS by 24c
• Norfolk Southern (NSC) Tops Q2 EPS by 29c